Literature DB >> 33865389

Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.

Elena M Yubero-Serrano1,2, Juan F Alcalá-Diaz3,4, Diego Gómez-Coronado4,5, Jose Lopez-Miranda6,7, Francisco M Gutierrez-Mariscal3,4, Antonio P Arenas-de Larriva3,4, Patricia J Peña-Orihuela3,4, Ruth Blanco-Rojo8, Javier Martinez-Botas4,5, Jose D Torres-Peña3,4, Pablo Perez-Martinez3,4, Jose M Ordovas9,10, Javier Delgado-Lista3,4.   

Abstract

Entities:  

Year:  2021        PMID: 33865389      PMCID: PMC8053258          DOI: 10.1186/s12933-021-01269-8

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


× No keyword cloud information.

Correction to: Cardiovasc Diabetol (2021) 20:72 https://doi.org/10.1186/s12933-021-01260-3

Following publication of the original article [1], the authors regret the error occurred in the article note for equally contribution. This has been corrected with this erratum. The correct statement is, “Elena M. Yubero-Serrano, Juan F. Alcalá-Diaz, Diego Gómez-Coronado and Jose Lopez-Miranda contributed equally to this work” instead of “Elena M. Yubero-Serrano and Jose Lopez-Miranda contributed equally to this work”. The original article has been corrected.
  1 in total

1.  Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.

Authors:  Elena M Yubero-Serrano; Juan F Alcalá-Diaz; Diego Gómez-Coronado; Jose Lopez-Miranda; Francisco M Gutierrez-Mariscal; Antonio P Arenas-de Larriva; Patricia J Peña-Orihuela; Ruth Blanco-Rojo; Javier Martinez-Botas; Jose D Torres-Peña; Pablo Perez-Martinez; Jose M Ordovas; Javier Delgado-Lista
Journal:  Cardiovasc Diabetol       Date:  2021-03-25       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.